News

SNAP heads into Q2 earnings with ad growth and AI tools in focus as geopolitical, restructuring and hardware pressures test results.

Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could shape its outlook.

HUM's Q2 earnings top estimates as medical membership growth, premium gains and CenterWell strength lift results despite higher costs.

WERN's second-quarter 2026 revenues benefit from growth in its Truckload Transportation Services segment, partially offset by a decline in the Logistics segment.

SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.

SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.

Reddit reports second-quarter earnings on July 30. Heading into the print, the stock is down about 27% year to date, and most of that damage came from one story. The Wall Street Journal recently reported that Reddit had internally discussed restricting Google’s access to its platform content for AI training, as renewal talks over their […]

POWL heads into Q3 earnings with expectations for double-digit growth, supported by a strong backlog and demand across utility and energy markets.

Skyworks Solutions tops fiscal Q3 estimates as Broad Markets growth, led by AI data center, offsets weaker revenues and margin pressure.

Meta stock was lower Wednesday morning, setting up a 10th straight losing day for the social media giant.

Microsoft Corp (NASDAQ:MSFT) reports fiscal fourth-quarter results tonight, with analysts largely centering their attention on capital expenditures as the company continues its aggressive buildout of AI infrastructure. Bank of America analysts said "AI execution remains the central debate"...

Here is what investors will be looking for when Meta Platforms reports its earnings after markets close today: One big question is whether Meta will increase its capital expenditure estimate for the year, like Alphabet did last week.

AppLovin (APP) is expected to deliver Q2 results above its guidance, supported by continued strength

CMI heads into Q2 earnings with higher FY2026 guidance and strong power demand, as investors watch if growth continues across key segments.

Biogen tops Q2 earnings and revenue estimates as growth drugs fuel sales, offset MS declines, and support a higher 2026 revenue and EPS outlook.

Marathon Petroleum (MPC) is drawing fresh attention as investors focus on its August 4 earnings report, with the stock recently touching record levels alongside other refiners during a strong sector run. See our latest analysis for Marathon Petroleum. At a share price of US$306.05, Marathon Petroleum has eased back over the past week, with the 7 day share price return down 4.29%. However, the 30 day share price return of 20.46% and year to date share price return of 85.33% keep momentum...

SWK tops Q2 estimates and raises its 2026 outlook after stronger margins, cash generation and improved operating performance.

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.

A single capital spending number from Microsoft could either rescue a $700 billion AI trade from its worst selloff in months or confirm that the boom is finally running out of steam. Every chipmaker on five continents is watching.

Asbury beats on Q2 earnings as used-vehicle profitability offsets weaker new-car margins, even though revenues miss estimates.

EOG heads into Q2 earnings with rising estimates, stronger oil prices and projected volume growth, though the model does not signal a beat.

Legrand SA (LGRDY) reports a robust 17.4% sales increase, driven by data center expansion and strategic acquisitions, despite currency challenges.

BP heads into Q2 earnings with higher estimates, supported by strong oil prices but tempered by lower seasonal production.

F's Q2 earnings beat as stronger pricing and product mix lifted EBIT, prompting higher 2026 profit and free cash flow guidance.

MSI's Q2 revenues are expected to rise as mission-critical technology demand and new AI tools support both business segments.

LSTR beats Q2 earnings and revenue estimates as stronger truck rates, load growth and rising BCO utilization powered gains.

GILD heads into Q2 earnings with HIV franchise strength, rising Yeztugo expectations and oncology progress, even as Cell Therapy faces competitive pressure.

Itron beat Q2 EPS estimates by 22.3% and raised its 2026 earnings outlook despite lower revenue, as strong margins and backlog fueled a sharp share rally.

GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.

Vertiv Holdings (VRT) stock sinks on Wednesday after missing its second quarter earnings estimates despite its increase to full-year guidance. Vertiv is a major player in AI data center infrastructure. Morning Brief Host Julie Hyman is joined by Yahoo Finance Senior Reporter Pras Subramanian and Breaking News Reporter Jake Conley to weigh in on the outlook for the rest of the major companies participating in the AI infrastructure buildout.